Hualan Biological Engineering, Inc.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE000001JN8
CNY
15.41
-0.12 (-0.77%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Dec'23
Net Sales
920.59
859.23
878.67
1,826.86
856.38
778.94
1,417.77
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
920.59
859.23
878.67
1,826.86
856.38
778.94
1,417.77
Raw Material Cost
501.42
407.33
380.25
545.93
493.45
376.42
463.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.76
2.74
1.57
3.17
3.70
4.50
0.77
Selling and Distribution Expenses
158.77
49.11
193.73
598.20
148.32
69.86
349.86
Other Expenses
8.15
5.30
10.77
5.21
5.45
5.44
4.91
Total Expenditure (Excl Depreciation)
744.40
512.22
683.28
1,199.42
699.95
505.22
862.77
Operating Profit (PBDIT) excl Other Income
176.20000000000002
347
195.39999999999998
627.4
156.4
273.7
555
Other Income
35.15
33.80
16.97
43.26
51.45
54.62
61.10
Operating Profit (PBDIT)
292.61
451.90
207.34
739.90
274.80
395.25
590.56
Interest
2.76
2.74
1.57
3.17
3.70
4.50
0.77
Exceptional Items
7.05
5.45
9.31
4.27
9.89
9.46
13.07
Gross Profit (PBDT)
419.17
451.89
498.42
1,280.93
362.93
402.52
954.78
Depreciation
70.04
70.04
69.20
69.20
66.92
66.92
69.38
Profit Before Tax
226.87
384.57
145.89
671.80
214.07
333.30
533.48
Tax
28.01
60.74
-4.46
102.46
31.14
54.00
37.74
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
202.72
313.14
164.19
483.46
178.42
261.77
414.29
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
202.72
313.14
164.19
483.46
178.42
261.77
414.29
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-3.86
10.70
-19.88
78.92
-4.02
12.60
75.11
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
198.86
323.83
144.31
562.38
174.40
274.37
489.40
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
12,013.17
12,172.14
11,858.78
11,697.01
11,249.89
11,631.48
11,359.43
Earnings per share (EPS)
0.11
0.17
0.09
0.26
0.1
0.14
0.23
Diluted Earnings per share
0.11
0.17
0.09
0.26
0.1
0.14
0.23
Operating Profit Margin (Excl OI)
20.36%
40.51%
13.79%
34.34%
18.27%
35.14%
32.45%
Gross Profit Margin
32.25%
52.91%
24.48%
40.56%
32.81%
51.38%
42.52%
PAT Margin
22.02%
36.44%
18.69%
26.46%
20.83%
33.61%
29.22%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2025 is 7.15% vs -2.22% in Mar 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2025 is -38.57% vs 124.39% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2025 is -38.41% vs 119.59% in Mar 2025

stock-summary

Interest

QoQ Growth in quarter ended Jun 2025 is 3.70% vs 68.75% in Mar 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

Compare Quarterly Results Of Hualan Biological Engineering, Inc. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
920.59
0
920.59
Other Operating Income
0.00
0.00
0.00
Total Operating income
920.59
0
920.59
Raw Material Cost
501.42
0
501.42
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
2.76
0
2.76
Selling and Distribution Expenses
158.77
0
158.77
Other Expenses
8.15
0.00
8.15
Total Expenditure (Excl Depreciation)
744.40
0
744.40
Operating Profit (PBDIT) excl Other Income
176.19
0.00
176.19
Other Income
35.15
0
35.15
Operating Profit (PBDIT)
292.61
0
292.61
Interest
2.76
0
2.76
Exceptional Items
7.05
0
7.05
Gross Profit (PBDT)
419.17
0
419.17
Depreciation
70.04
0
70.04
Profit Before Tax
226.87
0
226.87
Tax
28.01
0
28.01
Provisions and contingencies
0
0
0.00
Profit After Tax
202.72
0
202.72
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
202.72
0
202.72
Share in Profit of Associates
0
0
0.00
Minority Interest
-3.86
0
-3.86
Other related items
0.00
0.00
0.00
Consolidated Net Profit
198.86
0
198.86
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
12,013.17
0
12,013.17
Earnings per share (EPS)
0.11
0
0.11
Diluted Earnings per share
0.11
0
0.11
Operating Profit Margin (Excl OI)
20.36%
0%
0.00
20.36%
Gross Profit Margin
32.25%
0%
0.00
32.25%
PAT Margin
22.02%
0%
0.00
22.02%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 92.06 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 7.15% vs -2.22% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 7.50% vs 23.17% in Jun 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 19.89 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -38.57% vs 124.39% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 14.05% vs -2.95% in Jun 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 25.75 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is -38.41% vs 119.59% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is 15.32% vs -7.11% in Jun 2024

Quarterly - Interest
Interest 0.28 Million
in Jun 2025

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2025 is 3.70% vs 68.75% in Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 is -24.32% vs -28.85% in Jun 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 20.36%
in Jun 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025

stock-summary

YoY Growth in quarter ended Jun 2025 has improved from Jun 2024